Needham & Company LLC Reaffirms “Buy” Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $202.00 price objective on the specialty pharmaceutical company’s stock. Needham & Company LLC’s target price indicates a potential upside of […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $202.00 price objective on the specialty pharmaceutical company’s stock. Needham & Company LLC’s target price indicates a potential upside of […]
